Patient-reported outcomes and quality of life in advanced ALK+ non-small-cell lung cancer trial of brigatinib (ALTA).
暂无分享,去创建一个
R. Speck | C. Langer | W. Lenderking | D. Kerstein | H. Lin | Hui Huang | Yanyan Zhu | Joice Huang
暂无分享,去创建一个
R. Speck | C. Langer | W. Lenderking | D. Kerstein | H. Lin | Hui Huang | Yanyan Zhu | Joice Huang